 Shaun Bevers
Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcus pneumoniae | 2 | 2026 | 186 | 0.400 |
Why?
| | Aminoacyltransferases | 1 | 2026 | 13 | 0.240 |
Why?
| | Cysteine Endopeptidases | 1 | 2026 | 78 | 0.240 |
Why?
| | Ribonucleoprotein, U1 Small Nuclear | 1 | 2026 | 20 | 0.240 |
Why?
| | Azotemia | 1 | 2026 | 13 | 0.230 |
Why?
| | RNA Splicing Factors | 1 | 2026 | 66 | 0.230 |
Why?
| | Receptor, Adenosine A2B | 1 | 2025 | 65 | 0.220 |
Why?
| | Caffeine | 1 | 2025 | 74 | 0.220 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2025 | 70 | 0.220 |
Why?
| | Protein Domains | 2 | 2026 | 311 | 0.200 |
Why?
| | DNA, Z-Form | 1 | 2023 | 13 | 0.190 |
Why?
| | RNA Polymerase II | 1 | 2026 | 350 | 0.190 |
Why?
| | Postmenopause | 1 | 2025 | 394 | 0.180 |
Why?
| | Bacterial Proteins | 2 | 2026 | 968 | 0.180 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2026 | 414 | 0.180 |
Why?
| | beta-Globins | 1 | 2022 | 8 | 0.180 |
Why?
| | Amino Acids | 1 | 2026 | 519 | 0.180 |
Why?
| | Fibrinolysin | 1 | 2022 | 19 | 0.180 |
Why?
| | Saccharomyces cerevisiae | 1 | 2026 | 574 | 0.170 |
Why?
| | Erythrocytes | 2 | 2025 | 749 | 0.170 |
Why?
| | Vasodilation | 1 | 2025 | 521 | 0.170 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 171 | 0.170 |
Why?
| | Blood Preservation | 1 | 2025 | 346 | 0.170 |
Why?
| | Hematopoietic Stem Cells | 1 | 2024 | 435 | 0.160 |
Why?
| | Alu Elements | 1 | 2021 | 28 | 0.160 |
Why?
| | Adenosine Deaminase | 1 | 2021 | 43 | 0.160 |
Why?
| | Metabolomics | 1 | 2026 | 733 | 0.160 |
Why?
| | RNA, Ribosomal | 1 | 2021 | 168 | 0.160 |
Why?
| | Fibrinolysis | 1 | 2022 | 164 | 0.160 |
Why?
| | Energy Metabolism | 1 | 2026 | 935 | 0.150 |
Why?
| | Tissue Plasminogen Activator | 1 | 2022 | 248 | 0.150 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 693 | 0.150 |
Why?
| | Blood Coagulation Disorders | 1 | 2022 | 198 | 0.150 |
Why?
| | Acinetobacter baumannii | 1 | 2019 | 26 | 0.140 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2019 | 81 | 0.140 |
Why?
| | Endothelium, Vascular | 1 | 2025 | 956 | 0.140 |
Why?
| | Acute Kidney Injury | 1 | 2026 | 874 | 0.130 |
Why?
| | Alzheimer Disease | 1 | 2024 | 630 | 0.130 |
Why?
| | RNA-Binding Proteins | 1 | 2021 | 447 | 0.120 |
Why?
| | Macrophages | 1 | 2024 | 1507 | 0.120 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2016 | 23 | 0.120 |
Why?
| | Cell Adhesion Molecules | 1 | 2016 | 181 | 0.110 |
Why?
| | Receptors, Cell Surface | 1 | 2016 | 372 | 0.100 |
Why?
| | Signal Transduction | 2 | 2025 | 5226 | 0.100 |
Why?
| | Wounds and Injuries | 1 | 2022 | 963 | 0.100 |
Why?
| | Glycolysis | 2 | 2025 | 340 | 0.100 |
Why?
| | Hemolysis | 2 | 2025 | 242 | 0.080 |
Why?
| | Protein Structure, Secondary | 2 | 2023 | 371 | 0.080 |
Why?
| | Mice | 5 | 2026 | 18358 | 0.070 |
Why?
| | Nucleic Acid Conformation | 2 | 2023 | 724 | 0.070 |
Why?
| | Anti-Bacterial Agents | 1 | 2019 | 1925 | 0.070 |
Why?
| | Oxidative Stress | 2 | 2025 | 1361 | 0.070 |
Why?
| | T-Lymphocytes | 1 | 2016 | 1998 | 0.060 |
Why?
| | Substrate Specificity | 1 | 2026 | 387 | 0.060 |
Why?
| | Catalytic Domain | 1 | 2026 | 234 | 0.060 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2025 | 15 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2026 | 4568 | 0.050 |
Why?
| | RNA Splicing | 1 | 2026 | 284 | 0.050 |
Why?
| | Animals | 5 | 2026 | 38106 | 0.050 |
Why?
| | Premenopause | 1 | 2025 | 125 | 0.050 |
Why?
| | Amyloidogenic Proteins | 1 | 2024 | 16 | 0.050 |
Why?
| | Mice, Inbred C57BL | 2 | 2026 | 5995 | 0.050 |
Why?
| | Blood Donors | 1 | 2025 | 144 | 0.050 |
Why?
| | Pneumococcal Infections | 1 | 2025 | 104 | 0.050 |
Why?
| | Brachial Artery | 1 | 2025 | 208 | 0.050 |
Why?
| | Erythrocyte Transfusion | 1 | 2025 | 225 | 0.050 |
Why?
| | Metabolome | 1 | 2026 | 391 | 0.050 |
Why?
| | Plasma | 1 | 2024 | 223 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2026 | 765 | 0.040 |
Why?
| | alpha-Globins | 1 | 2022 | 9 | 0.040 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2024 | 238 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2025 | 611 | 0.040 |
Why?
| | RNA Recognition Motif | 1 | 2021 | 5 | 0.040 |
Why?
| | Metabolic Networks and Pathways | 1 | 2022 | 175 | 0.040 |
Why?
| | Circular Dichroism | 1 | 2021 | 151 | 0.040 |
Why?
| | Adult | 4 | 2025 | 40882 | 0.040 |
Why?
| | Thrombelastography | 1 | 2022 | 192 | 0.040 |
Why?
| | Protein Binding | 1 | 2026 | 2240 | 0.040 |
Why?
| | Humans | 8 | 2026 | 145785 | 0.040 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2019 | 18 | 0.040 |
Why?
| | Hemoglobins | 1 | 2022 | 386 | 0.040 |
Why?
| | Fibrinolytic Agents | 1 | 2022 | 297 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2025 | 878 | 0.030 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2021 | 347 | 0.030 |
Why?
| | Autoimmunity | 1 | 2024 | 933 | 0.030 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 192 | 0.030 |
Why?
| | Kidney | 1 | 2026 | 1497 | 0.030 |
Why?
| | Peptides | 1 | 2024 | 1000 | 0.030 |
Why?
| | Drug Design | 1 | 2019 | 175 | 0.030 |
Why?
| | Mitochondria | 1 | 2025 | 994 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2019 | 365 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2021 | 1368 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2025 | 4151 | 0.030 |
Why?
| | RNA | 1 | 2023 | 912 | 0.030 |
Why?
| | Nectins | 1 | 2016 | 7 | 0.030 |
Why?
| | DNA | 1 | 2023 | 1437 | 0.030 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 1 | 2016 | 104 | 0.030 |
Why?
| | Receptors, Virus | 1 | 2016 | 95 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 97 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2016 | 387 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2021 | 835 | 0.030 |
Why?
| | Proteomics | 1 | 2022 | 1188 | 0.030 |
Why?
| | Biomarkers | 1 | 2026 | 4302 | 0.030 |
Why?
| | Ligands | 1 | 2016 | 668 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2016 | 741 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2016 | 666 | 0.020 |
Why?
| | Prognosis | 1 | 2022 | 4330 | 0.020 |
Why?
| | Male | 3 | 2026 | 73012 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2016 | 501 | 0.020 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2016 | 673 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2016 | 2131 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2016 | 1133 | 0.020 |
Why?
| | Phylogeny | 1 | 2016 | 917 | 0.020 |
Why?
| | Female | 3 | 2025 | 79045 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2016 | 2883 | 0.020 |
Why?
| | Models, Molecular | 1 | 2016 | 1599 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2016 | 3551 | 0.020 |
Why?
| | Middle Aged | 1 | 2025 | 36309 | 0.010 |
Why?
|
|
Bevers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|